Clinical trial
Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
NCT00433368 · Aga Khan University, Other · Completed
Key facts
| NCT number | NCT00433368 |
|---|---|
| Title | Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy |
| Official title | Efficacy of a Three Days' Infusion of L-Ornithine-L-Aspartate as an Adjuvant Therapy in Cirrhotic Patients With Overt Hepatic Encephalopathy: A Placebo Controlled Study |
| Lead sponsor | Aga Khan University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatic Encephalopathy |
| Intervention type | Drug |
| Interventions | L-Ornithine L-Aspartate |
| Enrollment | 108 |
| Start date | Oct 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Feb 9, 2007 |
| Last update posted | Feb 9, 2007 |
| Countries | Pakistan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: